Approval Within 24 Hours
Search:

Bollywood Movie Review's Articles in Chiropractic

  • Cytokinetics Announces Oral Bioavailability Results For CK-1827452
    Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that the results from an oral bioavailability study evaluating CK-1827452, a novel cardiac myosin activator, in healthy volunteers support advancement of an oral formulation of CK-1827452 into Phase II clinical trials. The study was designed as an open-label, four way crossover study to investigate the absolute bioavailability, and the effects of food on the bioavailability, of two oral formulations of CK-1827452.


Help on Diabetes | Guitar FAQ | Art Auctions | Finance Web Sites | Q-Ray Bracelets | QRay Ionized Bracelets | Easy Cooking Recipes
| |

Powered by Article Dashboard